STEVEN BOEYNAEMS to Mice
This is a "connection" page, showing publications STEVEN BOEYNAEMS has written about Mice.
Connection Strength
0.023
-
Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2. Cell Rep. 2022 10 25; 41(4):111508.
Score: 0.015
-
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015 Sep; 18(9):1226-9.
Score: 0.009